Literature DB >> 10022897

Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment.

H Chan1, D P Bartos, L B Owen-Schaub.   

Abstract

Fas (CD95) and Fas ligand (CD95L) are an interacting receptor-ligand pair required for immune homeostasis. Lymphocyte activation results in the upregulation of Fas expression and the acquisition of sensitivity to FasL-mediated apoptosis. Although Fas upregulation is central to the preservation of immunologic tolerance, little is known about the molecular machinery underlying this process. To investigate the events involved in activation-induced Fas upregulation, we have examined mRNA accumulation, fas promoter activity, and protein expression in the Jurkat T-cell line treated with phorbol myristate acetate and ionomycin (P/I), pharmacological mimics of T-cell receptor activation. Although resting Jurkat cells express Fas, Fas mRNA was induced approximately 10-fold in 2 h upon P/I stimulation. Using sequential deletion mutants of the human fas promoter in transient transfection assays, we identified a 47-bp sequence (positions -306 to -260 relative to the ATG) required for activation-driven fas upregulation. Sequence analysis revealed the presence of a previously unrecognized composite binding site for both the Sp1 and NF-kappaB transcription factors at positions -295 to -286. Electrophoretic mobility shift assay (EMSA) and supershift analyses of this region documented constitutive binding of Sp1 in unactivated nuclear extracts and inducible binding of p50-p65 NF-kappaB heterodimers after P/I activation. Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50. The functional contribution of the kappaB-Sp1 composite site in P/I-inducible fas promoter activation was verified by using kappaB-Sp1 concatamers (-295 to -286) in a thymidine kinase promoter-driven reporter construct and native promoter constructs in Jurkat cells overexpressing IkappaB-alpha. Site-directed mutagenesis of the critical guanine nucleotides in the kappaB-Sp1 element documented the essential role of this site in activation-dependent fas promoter induction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10022897      PMCID: PMC84003          DOI: 10.1128/MCB.19.3.2098

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  63 in total

1.  Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness.

Authors:  L B Owen-Schaub; R Radinsky; E Kruzel; K Berry; S Yonehara
Journal:  Cancer Res       Date:  1994-03-15       Impact factor: 12.701

2.  Differential expression of APO-1 on human thymocytes: implications for negative selection?

Authors:  K M Debatin; D Süss; P H Krammer
Journal:  Eur J Immunol       Date:  1994-03       Impact factor: 5.532

3.  Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators.

Authors:  J L Chen; L D Attardi; C P Verrijzer; K Yokomori; R Tjian
Journal:  Cell       Date:  1994-10-07       Impact factor: 41.582

4.  FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex.

Authors:  M Muzio; A M Chinnaiyan; F C Kischkel; K O'Rourke; A Shevchenko; J Ni; C Scaffidi; J D Bretz; M Zhang; R Gentz; M Mann; P H Krammer; M E Peter; V M Dixit
Journal:  Cell       Date:  1996-06-14       Impact factor: 41.582

Review 5.  Transcription from TATA-less promoters: dihydrofolate reductase as a model.

Authors:  J C Azizkhan; D E Jensen; A J Pierce; M Wade
Journal:  Crit Rev Eukaryot Gene Expr       Date:  1993       Impact factor: 1.807

6.  Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.

Authors:  T Takahashi; M Tanaka; C I Brannan; N A Jenkins; N G Copeland; T Suda; S Nagata
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

7.  A set of inducible genes expressed by activated human monocytic and endothelial cells contain kappa B-like sites that specifically bind c-Rel-p65 heterodimers.

Authors:  G C Parry; N Mackman
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

8.  Structure of the human APO-1 gene.

Authors:  I Behrmann; H Walczak; P H Krammer
Journal:  Eur J Immunol       Date:  1994-12       Impact factor: 5.532

9.  Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes.

Authors:  M Tanaka; H Ito; S Adachi; H Akimoto; T Nishikawa; T Kasajima; F Marumo; M Hiroe
Journal:  Circ Res       Date:  1994-09       Impact factor: 17.367

10.  A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation.

Authors:  N D Perkins; N L Edwards; C S Duckett; A B Agranoff; R M Schmid; G J Nabel
Journal:  EMBO J       Date:  1993-09       Impact factor: 11.598

View more
  55 in total

1.  NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling.

Authors:  S Kreuz; D Siegmund; P Scheurich; H Wajant
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

2.  A unique role for ITK in survival of invariant NKT cells associated with the p53-dependent pathway in mice.

Authors:  Qian Qi; Weishan Huang; Yuting Bai; Gabriel Balmus; Robert S Weiss; Avery August
Journal:  J Immunol       Date:  2012-03-07       Impact factor: 5.422

Review 3.  Apoptosis: a mechanism of acute and chronic liver injury.

Authors:  M E Guicciardi; G J Gores
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

4.  Opposite roles of FAP-1 and dynamin in the regulation of Fas (CD95) translocation to the cell surface and susceptibility to Fas ligand-mediated apoptosis.

Authors:  Vladimir N Ivanov; Ze'ev Ronai; Tom K Hei
Journal:  J Biol Chem       Date:  2005-11-23       Impact factor: 5.157

5.  Loss of Fas-ligand expression in mouse keratinocytes during UV carcinogenesis.

Authors:  A Ouhtit; A Gorny; H K Muller; L L Hill; L Owen-Schaub; H N Ananthaswamy
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

Review 6.  Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack.

Authors:  Fade Mahmoud; Bradley Shields; Issam Makhoul; Nathan Avaritt; Henry K Wong; Laura F Hutchins; Sara Shalin; Alan J Tackett
Journal:  Cancer Biol Ther       Date:  2017-05-17       Impact factor: 4.742

7.  Functional Incompatibility between the Generic NF-κB Motif and a Subtype-Specific Sp1III Element Drives the Formation of the HIV-1 Subtype C Viral Promoter.

Authors:  Anjali Verma; Pavithra Rajagopalan; Rishikesh Lotke; Rebu Varghese; Deepak Selvam; Tapas K Kundu; Udaykumar Ranga
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

8.  TAp63 is a transcriptional target of NF-kappaB.

Authors:  Junfeng Wu; Johann Bergholz; Jinin Lu; Gail E Sonenshein; Zhi-Xiong Jim Xiao
Journal:  J Cell Biochem       Date:  2010-03-01       Impact factor: 4.429

9.  Muscle precursor cells isolated from aged rats exhibit an increased tumor necrosis factor- alpha response.

Authors:  Simon J Lees; Kevin A Zwetsloot; Frank W Booth
Journal:  Aging Cell       Date:  2009-02       Impact factor: 9.304

10.  Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide.

Authors:  Suwei Wang; Srigiridhar Kotamraju; Eugene Konorev; Shasi Kalivendi; Joy Joseph; Balaraman Kalyanaraman
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.